Lymphoma Clinical Trials

1. (CLYM05004) (S0433)A Phase II Study: Iodine - 131- Labeled Monocolonal Antibody (I-31 Tositumomab) In Combination with Cyslophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Patients > Age 60 with Advanced Stage Diffuse Large B-Cell NHL
2. (CLYM05003) (S0350)A Phase II Trial of Cisplatin plus Etoposide plus Gemcitabine plus Solumedrol in Peripheral T-Cell NHL
3. (CLYM08111) S0801 - A Phase II Study of Iodine -131- Labeled Tositumomab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Pateints with Advanced Stage Follicular Non-Hodgkins Lymphoma.
4. (ILYM08122) A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients with Aggressive Non-Hodgkins Lymphoma.
5. (ULYM07028) A Phase I/II Study of Clofarabine in Patients with Relapsed T-cell and NK-Cell Lymphoma